FEATURED COMPANIES
COMMENDED:
• Innovation
• Research and Development
VIEW PROFILE
COMMENDED:
• Innovation
• Research and Development
VIEW PROFILE
COMMENDED:
• Research and Development
VIEW PROFILE

The Excellence Rankings celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.

Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.

What is Research and Development (R&D)?

This category includes organisations that have demonstrated a commitment to the research and development of new products and/or new processes. This can include discovering or creating a unique material, transferring a research or technology development to practice, improving the performance of an existing product or creating a new simulation or design tools.

The category also includes companies that have made significant investments into their R&D processes.

Themes

The search for ever more efficient COVID drugs and vaccines has dominated the RnD field in the clinical trials industry. In terms of drug development, the focus has been on reducing complications using drug combinations and monoclonal antibody drugs. Some intranasal drugs have also been a source of hope for the industry.

Several trends are noteworthy in terms of COVID vaccine development. Clinical research organisations have gradually been lowering the age of participants in trials with a view to ascertaining the effects of their vaccines on adolescents. CRO’s have also been looking into dose-mixing and the efficacy of booster shots. Showing a durable immune response and protection against new variants have been key desirable features for new vaccine candidates.

Companies have also been putting time and investment into developing and evolving trial enrolment and trial management solutions during this research period.

Is your company ranked?

If you want to learn more about the Rankings and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:

Contact: Olga Kovalova – Olga.Kovalova@globaldata.com

Book a meeting with Olga – https://calendly.com/olga-kovalova

Ranking Categories

This category highlights medical companies and clinical research organisations that have conducted research and development in the field of age related diseases. This includes Alzheimer's disease, Parkinson’s as well as old age frailty.


This category includes medical companies and clinical research organisations that have conducted research and development in the field of asthma.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of cardiovascular diseases.


This category consists of medical companies and clinical research organisations that have distinguished themselves in phase I trials of COVID drugs.


This category comprises medical companies and clinical research organisations that have distinguished themselves in phase II trials of COVID drugs.


This category highlights medical companies and clinical research organisations that have distinguished themselves in phase III and IV trials of COVID drugs.


This category includes medical companies and clinical research organisations that have distinguished themselves in phase I trials of COVID vaccines.


This category highlights medical companies and clinical research organisations that have distinguished themselves in phase II trials of COVID vaccines.


This category comprises medical companies and clinical research organisations that have distinguished themselves in phases III and IV trials of COVID vaccines.


This category highlights medical companies and clinical research organisations that have conducted research and development in the field of dermatological conditions.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of diabetes.


This category highlights medical companies and clinical research organisations that have conducted research and development into the possible applications of drug combinations.


This category includes medical companies and clinical research organisations that have conducted research and development in the field of flu treatments and vaccines.


This category highlights medical companies and clinical research organisations that have conducted research and development in the field of hepatitis.


This category includes medical companies and clinical research organisations that have conducted HIV research and development.


This category highlights medical companies and clinical research organisations that have conducted research and development in the field of immune system conditions.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of infectious diseases.


This category includes medical companies and clinical research organisations that have conducted research and development in the field of inflammatory conditions.


This category consists of medical companies and clinical research organisations that have conducted research and development in the field of leukaemia.


This category highlights medical companies and clinical research organisations that have conducted research and development in the field of liver diseases.


This category highlights medical companies and clinical research organisations that have conducted research and development in the field of neurology.


The category consists of medical companies and clinical research organisations that have distinguished themselves in phase I trials of cancer drugs.


This category includes medical companies and clinical research organisations that have distinguished themselves in phase II trials of their cancer drugs.


This category highlights medical companies and clinical research organisations that have distinguished themselves in phases III and IV trials of cancer drugs.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of ophthalmology.


This category includes medical companies and clinical research organisations that have conducted paediatric research and development.


This category consists of medical companies and clinical research organisations that have conducted research and development in the field of pain relieving drugs.


This category comprises medical companies and clinical research organisations that have partnered for the development of drugs for age-related diseases.


This category comprises medical companies and clinical research organisations that have partnered for the development of AI technologies.


This category comprises medical companies and clinical research organisations that have partnered in the development of drugs and vaccines for COVID-19.


This category comprises medical companies and clinical research organisations that have partnered for drug development projects.


This category highlights medical companies and clinical research organisations that have partnered for various projects related to health data.


This category consists of medical companies and clinical research organisations that have partnered to conduct research and development in the field of oncology.


This category includes medical companies and clinical research organisations that have partnered for various technology-related projects.


This category highlights medical companies and clinical research organisations that have partnered for vaccine development during the research period.


This category comprises medical companies and clinical research organisations that have conducted research and development of pulmonary medicines.


This category includes medical companies and clinical research organisations that have conducted research and development of rare diseases drugs.


This category includes medical companies and clinical research organisations that have contributed to trial decentralisation during the research period.


This category consists of medical companies and clinical research organisations that have contributed to trial enrolment during the research period.


This category highlights medical companies and clinical research organisations that have contributed to trial management during the research period.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of urology.


This category consists of medical companies and clinical research organisations that have distinguished themselves in the development of vaccines. during this research period.


This category comprises medical companies and clinical research organisations that have conducted research and development in the field of women’s health.